Hydroxyzine Medical Valley (Hydroxyzine Hydrochloride)

Hydroxyzine works by selectively blocking peripheral histamine H1 receptors, which reduces allergic reactions, and by crossing the blood‑brain barrier to exert central sedative and anticholinergic effects that help calm anxiety and prevent nausea.

The appropriate dose of Hydroxyzine Medical Valley is determined by the prescribing healthcare professional based on the patient’s condition, age, weight, and response to therapy. Patients should follow the prescriber’s instructions exactly.

Hydroxyzine is classified as Pregnancy Category B, indicating that animal studies have not shown risk to the fetus, but there are limited human data. It should be used only if the potential benefit outweighs any possible risk, and breastfeeding mothers should consult their physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Hydroxyzine is a first‑generation antihistamine, which provides both peripheral H1 blockade and central sedation. Unlike newer second‑generation antihistamines that cause less drowsiness, hydroxyzine’s sedative properties make it useful for anxiety and pre‑operative sedation, but also increase the likelihood of CNS side effects.

Hydroxyzine Medical Valley should be stored at ambient temperature below 25 °C, in its original packaging, protected from moisture and direct light to maintain stability and potency.

Hydroxyzine Medical Valley is taken orally, usually as a tablet or liquid preparation, as directed by a healthcare professional. It should be swallowed with water and taken with or without food according to the prescriber’s guidance.

Serious risks include severe allergic reactions such as anaphylaxis, cardiac arrhythmias or QT prolongation, seizures, and rare blood disorders. Patients should seek immediate medical attention if they experience symptoms like rash, difficulty breathing, palpitations, or unexplained bruising.

Hydroxyzine should be avoided in individuals with known hypersensitivity to hydroxyzine or other first‑generation antihistamines, in patients taking monoamine oxidase inhibitors, and in those with severe liver impairment or prolonged QT interval unless specifically directed by a physician.